Sectors
LIMN
Liminatus Pharma, Inc.
4.00
1 x 3.84
1 x 5.16
bid
ask
-
0.23
5.44%
02:00 PM
timesize
| Ytd | -86.89% | |
| 1y | -97.05% |
3.80
day range
4.26
3.80
52 week range
154.50
| Open | 4.24 | Prev Close | 4.23 | Low | 3.80 | High | 4.26 | Mkt Cap | 5.37M |
| Vol | 41.67K | Avg Vol | 692.84K | EPS | -24.00 | P/E | N/A | Forward P/E | N/A |
| Beta | 5.35 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 5.67 | 200-d Avg | 19.75 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 1.38M | ||
| Research and Development Expense | 600.00K | ||
| Selling, General and Administrative Expense | 778.91K | ||
| Operating Income | -1.38M | ||
| Interest Expense | 18.84K | ||
| Net Income | -1.41M | ||
| Net Income Common Stock | -1.41M | ||
| Net Income Common Stock (USD) | -1.41M | ||
| Consolidated Income | -1.41M | ||
| Earnings per Basic Share | -1.50 | ||
| Earnings per Basic Share (USD) | -1.50 | ||
| Earnings per Diluted Share | -1.50 | ||
| Earning Before Interest & Taxes (EBIT) | -1.39M | ||
| Earning Before Interest & Taxes (USD) | -1.39M | ||
| Weighted Average Shares | 967.97K | ||
| Weighted Average Shares Diluted | 967.97K | ||
| Balance Sheet | |||
| Cash and Equivalents | 3.02M | ||
| Cash and Equivalents (USD) | 3.02M | ||
| Current Assets | 3.39M | ||
| Property, Plant & Equipment Net | 11.24K | ||
| Total Assets | 3.40M | ||
| Debt Current | 1.44M | ||
| Total Debt | 1.44M | ||
| Current Liabilities | 3.04M | ||
| Total Liabilities | 3.10M | ||
| Accumulated Retained Earnings (Deficit) | -41.40M | ||
| Shareholders Equity | 300.61K | ||
| Shareholders Equity (USD) | 300.61K | ||
| Assets Non-Current | 11.24K | ||
| Total Debt (USD) | 1.44M | ||
| Liabilities Non-Current | 62.67K | ||
| Trade and Non-Trade Payables | 856.52K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 468.00 | ||
| Net Cash Flow from Financing | 2.08M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 1.11M | ||
| Issuance (Purchase) of Equity Shares | 2.08M | ||
| Net Cash Flow from Operations | -970.00K | ||